Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinorna

World Journal of Gastroenterology

Volumn 14, Issue 13, 2008, Pages 1997-2002

  Taniguchi, Miyuki ^a   Kim, Soo Ryang ^a   Imoto, Susumu ^a   Ikawa, Hirotsugu ^a   Ando, Kenji ^a   Mita, Keiji ^a   Fuki, Shuichi ^a   Sasase, Noriko ^a   Matsuoka, Toshiyuki ^b   Kudo, Masatoshi ^c   Hayashi, Yoshitake ^d  

^a KOBE ASAHI HOSPITAL   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatocellular carcinoma; Interventional ablation; Percutaneous ethanol injection; Prognosis; Ultrasound

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN;

ADULT; AGED; ARTERY BLOOD FLOW; ARTICLE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; MALE; METASTASIS; OVERALL SURVIVAL; PORTAL VEIN BLOOD FLOW; PROGNOSIS; PROTEIN BLOOD LEVEL; RADIOFREQUENCY ABLATION; SURVIVAL RATE; TREATMENT DURATION; TUMOR VOLUME; UNSPECIFIED SIDE EFFECT;

EID: 44849103916     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.1997     Document Type: Article

References (18)

1. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 7: 462-503
2. Okuda K, Peters RL, Simson IW. Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas. Proposal of new classification. Cancer 1984; 54: 2165-2173
3. Trevisani F, Caraceni P, Bernardi M, D'Intino FE, Arienti V, Amorati P, Stefanini GF, Grazi G, Mazziotti A, Fornale L. Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors. Cancer 1993; 72: 1557-1563
4. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986; 6: 729-738
5. Kim SR, Kang KB, Soh CG, Kim JH, Hayashi Y, Hanioka K, Itoh H. Clinicopathological study of minimum-sized hepatocellular carcinoma: an approach to the definition of early hepatocellular carcinoma. J Gastroenterol Hepatol 1995; 10: 498-508
6. Bartolozzi C, Lencioni R. Ethanol injection for the treatment of hepatic tumours. Eur Radiol 1996; 6: 682-696
7. Lencioni R, Pinto F, Armillotta N, Bassi AM, Moretti M, Di Giulio M, Marchi S, Uliana M, Della Capanna S, Lencioni M, Bartolozzi C. Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience. Eur Radiol 1997; 7: 514-519
8. Ebara M, Okabe S, Kita K, Sugiura N, Fukuda H, Yoshikawa M, Kondo F, Saisho H. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol 2005; 43: 458-464
9. Vilana R, Bruix J, Bru C, Ayuso C, Sole M, Rodes J. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology 1992; 16: 353-357
10. Kojiro M. The evolution of pathologic features of hepatocellular carcinoma. In: Tabor E, ed. Viruses and liver cancer. Amsterdam: Elsevier, 2002: 113-122
11. Lencioni R, Caramella D, Bartolozzi C. Hepatocellular carcinoma: use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection. Radiology 1995; 194: 113-118
12. Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 2000; 88: 538-543
13. Kudo M, Chung H, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y, Matsunaga T. Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score. Hepatology 2004; 40: 1396-1405
14. Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, Makuuchi M, Nakamura Y, Okita K, Yamada R. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000; 32: 1224-1229
15. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210: 655-661
16. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, Frings H, Laubenberger J, Zuber I, Blum HE, Bartolozzi C. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-240
17. Shiina S, Teratani T, Obi s, Sato S, Tateishi R, Fujishima T, Ishikawa T, Koike Y, Yoshida H, Kawabe T, Omata M. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-130
18. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology 2004; 127: 1714-1723